A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18665164

Br. J. Cancer 2008 Aug 19 99 4 584-90

Download in:

View as

General Info

PMID
18665164